TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event

Insider Trading

Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.

Reset
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
Ticker Insider Title Date Transaction Price ($) Shares Value ($) SEC Form 4
CRDO Fleming Daniel W. Chief Financial Officer 10/05/2026 Steuer-Abgabe 218.64 2,460 537,854 Form 4
CBRS Feldman Andrew D. CEO, President 10/05/2026 J — 159 — Form 4
CARL Bertolini Jeffrey Chief Operating Officer 10/05/2026 Verkauf 14.39 747 10,749 Form 4
CARL Bertolini Jeffrey Chief Operating Officer 10/05/2026 Optionsausübung 5.92 747 4,419 Form 4
CRCT Ashish Arora Chief Executive Officer 10/05/2026 Verkauf 6.43 60,000 386,064 Form 4
CSHR Masters Daniel Director 10/05/2026 Verkauf 4.89 33,334 162,860 Form 4
CLOV Reynoso Jamie L. CEO, Medicare Advantage 10/05/2026 Verkauf 4.42 8,750 38,675 Form 4
CXDO Gaylor Douglas Walter Chief Operating Officer 10/04/2026 Steuer-Abgabe 5.92 77 456 Form 4
CXDO Gaylor Douglas Walter Chief Operating Officer 10/04/2026 Optionsausübung — 278 — Form 4
CXDO Korn Jeffrey G Chief Executive Officer 10/04/2026 Steuer-Abgabe 5.92 68 403 Form 4
CXDO Korn Jeffrey G Chief Executive Officer 10/04/2026 Optionsausübung — 278 — Form 4
CXDO Vincent Ron Chief Financial Officer 10/04/2026 Steuer-Abgabe 5.92 118 699 Form 4
CXDO Vincent Ron Chief Financial Officer 10/04/2026 Optionsausübung — 278 — Form 4
CURV Zeterberg Bridgett C. See Remarks 10/04/2026 Steuer-Abgabe 2.50 2,316 5,790 Form 4
COE Shu Ting Director 10/02/2026 Steuer-Abgabe 10.46 4,020 42,049 Form 4
COE Huang Jack Jiajia Chief Executive Officer 10/02/2026 Steuer-Abgabe 10.46 4,020 42,049 Form 4
CRWD Kurtz George PRESIDENT AND CEO 10/02/2026 Verkauf 272.53 317 86,392 Form 4
CRWD Kurtz George PRESIDENT AND CEO 10/02/2026 Verkauf 271.36 1,455 394,829 Form 4
CRWD Kurtz George PRESIDENT AND CEO 10/02/2026 Verkauf 270.44 1,308 353,736 Form 4
CRWD Kurtz George PRESIDENT AND CEO 10/02/2026 Verkauf 269.40 5,000 1,347,000 Form 4
CRWD Kurtz George PRESIDENT AND CEO 10/02/2026 Verkauf 268.47 1,920 515,462 Form 4
CRDO Brennan William Joseph Pres & Chief Executive Officer 10/02/2026 Steuer-Abgabe 210.17 6,149 1,292,335 Form 4
CRDO Fleming Daniel W. Chief Financial Officer 10/02/2026 Steuer-Abgabe 210.17 2,460 517,018 Form 4
CRBG Nippon Life Insurance Co 10% Owner 10/02/2026 Kauf 34.27 187,155 6,414,045 Form 4
CLBK Kemly Thomas J. President & CEO 10/02/2026 Zuteilung 11.41 163 1,860 Form 4
CLBK Klimowich John SEVP & Chief Risk Officer 10/02/2026 Zuteilung 11.41 60 685 Form 4
CLBK Holland Noel R. Director 10/02/2026 Zuteilung 11.41 15 171 Form 4
CHRN Davis Scott G. Director 10/02/2026 Zuteilung — 51,626 — Form 4
CARG Sarnoff Dafna Chief Marketing Officer 10/02/2026 Zuteilung — 5,911 — Form 4
CARG Quinn Matthew Todd Chief Technology Officer 10/02/2026 Zuteilung — 5,911 — Form 4
CRCT Ashish Arora Chief Executive Officer 10/02/2026 Verkauf 6.52 60,000 391,056 Form 4
CPNG Lee Jonathan D. Chief Accounting Officer 10/02/2026 Verkauf 13.65 5,519 75,339 Form 4
COIN Andreessen Marc L Director 10/02/2026 Verkauf 198.00 6,838 1,353,924 Form 4
CSHR Masters Daniel Director 10/02/2026 Verkauf 4.95 33,333 164,955 Form 4
CRCL Fox-Geen Jeremy Chief Financial Officer 10/02/2026 Verkauf 85.78 4,238 363,536 Form 4
CRCL Razzaghi Hossein Chief Commercial Officer 10/02/2026 Verkauf 85.78 1,830 156,977 Form 4
CRCL Schulz Tamara L Chief Accounting Officer 10/02/2026 Verkauf 85.78 1,194 102,421 Form 4
CDNA Goldberg Michael Director 10/02/2026 Zuteilung — 588 — Form 4
CARG Sarnoff Dafna Chief Marketing Officer 10/02/2026 Verkauf 29.62 7,234 214,271 Form 4
CARG Quinn Matthew Todd Chief Technology Officer 10/02/2026 Verkauf 29.62 3,824 113,267 Form 4
CARG Elshareef Ismail Chief Product Officer 10/02/2026 Verkauf 29.62 2,673 79,174 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Verkauf 116.59 5,147 600,063 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Verkauf 115.73 2,086 241,412 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Verkauf 114.52 1,100 125,973 Form 4
CORT Vieira Roberto Wandenkolk President, Oncology 10/02/2026 Optionsausübung 21.63 8,333 180,243 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Verkauf 116.54 4,744 552,869 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Verkauf 115.70 4,446 514,389 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Optionsausübung 19.26 5,833 112,344 Form 4
CORT Lyon Joseph Douglas See Remarks 10/02/2026 Optionsausübung 13.56 3,357 45,521 Form 4
CORT Maduck Sean See Remarks 10/02/2026 Verkauf 116.55 8,744 1,019,143 Form 4
CORT Maduck Sean See Remarks 10/02/2026 Verkauf 116.12 15,843 1,839,741 Form 4
CORT Maduck Sean See Remarks 10/02/2026 Optionsausübung 8.27 24,587 203,334 Form 4
COHU Muller Luis A President & CEO 10/02/2026 Verkauf 73.00 21,662 1,581,326 Form 4
CZNC Shattuck Katherine W Director 10/02/2026 Kauf 25.51 8 204 Form 4
CZNC Pellegrino Frank G Director 10/02/2026 Kauf 25.51 245 6,250 Form 4
CRDO Lam Yat Tung Chief Operating Officer 10/02/2026 Steuer-Abgabe 210.17 3,180 668,341 Form 4
CDLX Gupta Amit Chief Executive Officer 10/02/2026 Verkauf 2.53 7,382 18,699 Form 4
CNS Villani Edmond D Director 10/02/2026 Schenkung — 442 — Form 4
COE Lai Jimmy Y. Director 10/01/2026 Optionsausübung — 23,505 — Form 4
CIEN Smith Gary B President & CEO 10/01/2026 Verkauf 369.66 2,952 1,091,238 Form 4

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Was this page helpful to you?